Pancreatic, hepatic and biliary malignancies

Uncommon genetic aberrations NTRK, RET, NRG

Updates on triple negative breast cancer and immunotherapy

ASCO 2024: Lung cancer highlights

Isatuximab in combination with pomalidomide and dexamethasone shows promising efficacy in 2nd line RRMM

Patient expectations and shared decision making in aRCC

Immunotherapy significantly increases the number of patients free from bowel cancer

Encouraging results using mismatched unrelated donors in stem cell transplantation

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy

ASCO 2024: Highlights and analysis

ASCO 2024: Advances in NSCLC

ASCO 2024: Two studies report on isatuximab combos in transplant-ineligible patients with newly diagnosed multiple myeloma